Biotechnology
THE.WAVE.TALK raises US$2M
SEOUL, South Korea, April 7, 2020 /PRNewswire/ -- THE.WAVE.TALK, a member company of theBorn2Global Centre, successfully attracted a funding of USD 2 million in early February from Yellowdog and Silicon Valley-based Big Basin Capital, bringing its accumulated total to approximately USD 6 million ...
2020-04-07 20:30
1368
Merck Awarded Second U.S. Patent for CRISPR Gene-Editing Technology
- CRISPR-chrom technology improves access to genome for more efficient editing - Only U.S. patent holder in the CRISPR chromatin space - Company driving innovation in CRISPR gene-editing technologies DARMSTADT, Germany, April 7, 2020 /PRNewswire/ -- Merck, a leading science and technology compan...
2020-04-07 20:00
3063
CROMSOURCE Announces Launch of COVID-19 Clinical Trial
VERONA, Italy, 7 April, 2020 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) with its global headquarters inVerona, Italy, has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company. This trial is expected to be pe...
2020-04-07 19:01
2738
Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
SONGDO, South Korea, April 5, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline, a next generation therapeutic antibody candidate to treat oncology and neovascular disorders. Under th...
2020-04-06 08:00
1173
Gracell Announces China NMPA Acceptance of Investigational New Drug Application for GC007g Cell Therapy for CD19 Positive Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
SHANGHAI and SUZHOU, China, April 3, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell & gene therapy company, is pleased to announce that China National Medical Products Administration (NMPA) has accepted Gracell's Investigational New Drug (IND) ...
2020-04-03 22:00
1955
CMAB Biopharma Appoints Mr. Ye Shi as Head of Quality
SUZHOU, China, April 3, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated biologics contract manufacturing and development organization (CDMO), today announced the appointment of Mr. Ye Shi as the Head of Quality. He will be responsible for the overall management of the qual...
2020-04-03 09:12
5060
Atomo secures significant European sales agreement for rapid COVID-19 tests as $30m Initial Public Offer closes oversubscribed
SYDNEY, April 3, 2020 /PRNewswire/ -- Australian rapid blood test company Atomo Diagnostics Limited today said it had entered into a binding supply agreement with French diagnostics company, NG Biotech, SAS (NG Biotech), for the supply of Atomo's integrated blood test devices to NG Biotech to use...
2020-04-02 21:01
2129
Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment
Treatment with DAS181, a clinical-stage recombinant biologic, reduced or eliminated the need for supplemental oxygen, and improved key patient vital signs SAN DIEGO, April 2, 2020 /PRNewswire/ -- Ansun Biopharma, Inc., a clinical stage biopharmaceutical company, today announced preliminary data ...
2020-04-02 19:00
2289
Neteera, the Global Leader in Contact-free Vital Signs Monitoring, Launches Contactless Vital Signs Sensing System for COVID-19 Early Screening and Home Care
JERUSALEM, March 31, 2020 /PRNewswire/ -- As the world grapples with the current COVID-19 (Coronavirus) pandemic, the spotlight has been thrown on the interface between those afflicted by the virus, and the infrastructure delivering essential treatment to those in urgent need. It is precisely at...
2020-04-01 13:37
2652
GenScript Biotech Reports 2019 Financial Results and Provides Business Update
NANJING, China, April 1, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a leading global biotechnology company, yesterday reported full year 2019 financial results and provided a corporate update. In 2019, overall revenue of the Group was approximatelyUS$273.4 million, repres...
2020-04-01 08:36
12956
Viva Biotech Announced 2019 Annual Results
Financial Highlights For the year ended December 31, 2019 * Revenue amounted to approximately RMB323.1 million, representing a significant YOY increase of 53.9% from approximatelyRMB210.0 million in the same period last year. * Gross profit amounted to approximately RMB155.9 million, represe...
2020-03-31 11:45
3965
Innovent Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Progress
SUZHOU, China, March 30, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune, metabolic and oth...
2020-03-31 00:08
4264
ImmuneMed's 'hzVSF,' Used for Treatment of COVID-19 Pneumonia Patients
CHUNCHEON, South Korea, March 30, 2020 /PRNewswire/ -- 'hzVSF v13 (humanized Virus Suppressing Factor; VSF)', a treatment that can be used for a wide range of viral diseases developed by ImmuneMed, was administered onMarch 28th at Yonsei University Hospital to treat COVID-19 pneumonia patients...
2020-03-30 21:00
1084
Samsung Biologics expands leadership for CDO business
SONGDO, South Korea, March 30, 2020 /PRNewswire/ -- Samsung Biologics
(207940.KS) has appointedEun Young Yang as vice president of business
development for the company's expanded CDO (contract development organization)
business.
2020-03-30 21:00
1544
Tiger Asia Intelligence Initiates Coverage on AnPac Bio, Ltd
NEW YORK, March 30, 2020 /PRNewswire/ -- Tiger Asia Intelligence has announced it has initiated coverage on AnPac Bio, Ltd (NASDAQ: ANPC). The full report can be found here: AnPac Report Key Report Highlights: AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) is a biotechnology company with op...
2020-03-30 20:30
2751
Fapon Donation Reaches 3 Million PCR Test Components Globally and Welcomes More Participation
DONGGUAN, China, March 30, 2020 /PRNewswire/ -- Fapon Biotech Inc
2020-03-30 20:15
2401
Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Device
The device is designed to restore vision to persons blinded by age-related macular degeneration and retinitis pigmentosa First two patients to receive the device in March 2020 report visual effect HERZLIYA, Israel, March 30, 2020 /PRNewswire/ -- Nano Retina Ltd., developer of the NR600, an artif...
2020-03-30 08:00
2024
Foresee Pharmaceuticals and Accord Healthcare Announce MAA Submission for Camcevi(R) 42mg
TAIPEI, March 27, 2020 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee") and Accord Healthcare announced today that a Marketing Authorization Application (MAA) forCamcevi® 42mg (FP-001 LMIS 50mg), a ready-to-use 6-month depot formulation of leuprolide mesylate, has been su...
2020-03-27 19:53
3984
C(2) PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment
LUXEMBOURG, March 27, 2020 /PRNewswire/ -- C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of the active pharmaceutical ingredient (API), Digoxin. In early March,...
2020-03-27 07:33
2579
WuXi Biologics Achieved Remarkable Results in 2019
57.2% Revenue Growth to RMB3,983.7 Million 63.0% Gross Profit Growth to RMB1,658.8 Million Adjusted Net Profit Up 60.3% to RMB1,205.0 Million Diluted EPS of RMB0.76 and Adjusted Diluted EPS of RMB0.91, Increasing 58.3% and 59.6% Backlog Increased 40.2% to US$5.1 Billion Milestone Payments Surg...
2020-03-26 21:32
5992
Week's Top Stories
Most Reposted
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
[Picked up by 313 media titles]
2025-01-22 15:38
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 309 media titles]
2025-01-21 16:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 306 media titles]
2025-01-20 14:27
Blackpanda Recognized with Frost & Sullivan's Asia Pacific Company of the Year Award for Incident Response Excellence
[Picked up by 300 media titles]
2025-01-23 09:00
Infobip Research Unveils Opportunities for Brands to Engage Customers with Rich Communication Services (RCS) across APAC
[Picked up by 291 media titles]
2025-01-20 21:09
Most Read
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
2025-01-21 16:00
6634
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
2025-01-20 14:27
4915
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
2025-01-22 15:38
4478
